Faster, safer lab score to diagnose heart attacks developed

Image
IANS Toronto
Last Updated : Aug 20 2018 | 2:11 PM IST

Researchers have developed a simple laboratory score which is safer and faster at diagnosing patients who visit the emergency department with heart attack symptoms.

The findings, published in the CMAJ (Canadian Medical Association Journal), suggest that the score can also identify patients at risk of subsequent heart issues after discharge.

"We have developed a simple lab score that is superior to using cardiac troponin alone for the identification of patients at low and high risk for heart attack or death at emergency department presentation," said co-author Peter Kavsak from the McMaster University in Ontario, Canada.

"This lab score may reduce both the number of blood tests and the time spent in the emergency department for chest pain patients," Andrew Worster, Professor at the varsity, said.

For the study, the team combined common laboratory blood tests available at several hospitals around the world to create a single laboratory score or clinical chemistry score, to diagnose a heart attack.

These blood tests are part of the World Health Organization's (WHO) list of essential in vitro diagnostic tests for health care facilities with clinical laboratories.

The researchers validated the clinical chemistry score as a predictor of heart attacks or deaths within 30 days, using the data on 4,245 patients from emergency department studies in four countries -- Canada, Australia, New Zealand, and Germany.

Within one month of the emergency department visits, 727 heart attacks or deaths in patients occurred.

A negative (or low-risk) clinical chemistry score at emergency department presentation missed only one of these events compared with up to 25 missed heart attacks or deaths when using a high-sensitivity cardiac troponin test alone.

A positive (or high-risk) clinical chemistry score also identified about 75 per cent of the patients at high risk of heart attacks or deaths when positive compared with a low of 40 per cent detected when the high-sensitivity cardiac troponin test alone was positive.

The researchers suggest the score can be useful for standardising diagnoses and improving safety.

--IANS

vc/mag/bg

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 20 2018 | 2:06 PM IST

Next Story